Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL54682 | 0.89 | KMT2A (0.46) | ALDH1A1HPGDMEN1KMT2AHSD17B10 | |
| SCHEMBL38726 | 0.87 | TDP1 (0.61) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL11904537 | 0.87 | TDP1 (0.61) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL18074260 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| Bromide SCHEMBL20513084 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL23727166 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| Fluoride SCHEMBL20513066 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| Fluoride SCHEMBL21331933 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL16240294 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL18074258 | 0.84 | TDP1 (0.58) | TDP1ALDH1A1HPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479834-B2 | Phenol compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-12428389-B2 | Diarylamide compound and application thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2025-09-30 | — | — | US | disclosed |
| US-11905362-B2 | Polymers and methods of producing thereof | ORIGIN MATERIALS OPERATING, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| CN-114163407-B | Furan ring component for inhibiting or killing microorganism, product containing the same and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-10-24 | — | — | CN | disclosed |
| US-20230049402-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO. LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20230045031-A1 | Diarylamide Compound and Application Thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| US-20230045031-A1 | Diarylamide Compound and Application Thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-4067343-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2022-10-05 | — | — | EP | disclosed |
| EP-4006078-A1 | POLYMER COMPOUND COMPRISING BIOMASS-DERIVED CYCLIC MONOMER AND PREPARATION METHOD THEREFOR | Kolon Industries, Inc. (KR) | 2022-06-01 | — | — | EP | disclosed |
| EP-0320628-B1 | Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase | ABBOTT LAB (US) | 1997-01-15 | — | — | EP | disclosed |
| EP-0399645-B1 | Tetrahydropyranyl derivatives, process for their preparation and pharmaceutical or veterinary compositions containing them | BEECHAM GROUP PLC (GB) | 1994-11-09 | — | — | EP | disclosed |
| US-5112848-A | Antiasthmatics and antiarthritic agents | ABBOTT LABORATORIES (US) | 1992-05-12 | — | — | US | disclosed |
| EP-0388429-A4 | FURAN AND PYRROLE CONTAINING LIPOXYGENASE INHIBITING COMPOUNDS | — | 1991-08-21 | — | — | EP | disclosed |
| EP-0399645-A2 | Tetrahydropyranyl derivatives, process for their preparation and pharmaceutical or veterinary compositions containing them | BEECHAM GROUP PLC (GB) | 1990-11-28 | — | — | EP | disclosed |
| CN-1046332-A | New compound | BEECHAM GROUP PLC (GB) | 1990-10-24 | — | — | CN | disclosed |
| EP-0388429-A1 | FURAN AND PYRROLE CONTAINING LIPOXYGENASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1990-09-26 | — | — | EP | disclosed |
| EP-0320628-A1 | Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase | ABBOTT LABORATORIES (US) | 1989-06-21 | — | — | EP | disclosed |
| WO-1989004299-A1 | FURAN AND PYRROLE CONTAINING LIPOXYGENASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1989-05-18 | — | — | WO | disclosed |
| US-4814341-A | HISTAMINE H2 ANTAGONISTS | REITER LAWRENCE A (US) | 1989-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428389-B2 | Diarylamide compound and application thereof | SLC14A1, SLC28A1, SLC28A2 | TDP1 3295/4885ALDH1A1 903/4885HPGD 1055/4885 |
| US-12479834-B2 | Phenol compound or salt thereof | REN, MLX, MYB | TDP1 3948/4885ALDH1A1 287/4885HPGD 4260/4885 |
| US-11905362-B2 | Polymers and methods of producing thereof | HPD, PARN, PARG | TDP1 1654/4885ALDH1A1 795/4885HPGD 49/4885 |
| US-20230049402-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | MYB, MLX, EP300 | TDP1 3715/4885ALDH1A1 235/4885HPGD 4347/4885 |
| US-20230045031-A1 | Diarylamide Compound and Application Thereof | SLC14A1, SLC28A1, SLC28A2 | TDP1 3295/4885ALDH1A1 903/4885HPGD 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.